Dr. James C. L. Chow | Quantum Computing | Best Researcher Award

Dr. James C. L. Chow | Quantum Computing | Best Researcher Award

Princess Margaret Cancer Centre, Canada.

Dr. James Chun Lam Chow, PhD, FCCPM, FInstP, FIET, SMIEEE, PPhys, CPhys, CSci, is a distinguished medical physicist specializing in radiation oncology and artificial intelligence applications in healthcare. He is currently an Associate Professor in Material Science and Engineering at the University of Toronto and a Clinician Investigator at the Princess Margaret Cancer Research Institute. With over two decades of experience in medical physics, his research focuses on AI-driven healthcare solutions, radiation therapy optimization, and Monte Carlo simulations for cancer treatment.

Profile

Google Scholar

Education🎓

Dr. James C. L. Chow earned his PhD in Physics from the University of Hong Kong in 1995 under the supervision of Prof. Peter Fung, following a BSc in Applied Physics (First Class Honours) from City University of Hong Kong in 1992. He was awarded a Croucher Postdoctoral Fellowship at the University of Cambridge (1995-1997), then continued his research as a Postdoctoral Researcher at the University of Toronto (1997-1998) and later as a Postdoctoral Fellow at McMaster University (1998-2000). Transitioning into medical physics, he completed his Medical Physics Residency at the London Regional Cancer Centre (2000-2002), gaining clinical expertise in radiation therapy and medical imaging.

Professional Experience🌟

Dr. James C. L. Chow is an accomplished medical physicist and academic with extensive experience in radiation oncology and materials science. He is currently an Associate Professor in the Department of Materials Science and Engineering at the University of Toronto (2025–Present) and has been an Associate Professor in the Department of Radiation Oncology at the University of Toronto since 2019. In addition to his academic roles, he serves as a Medical Physicist at Princess Margaret Cancer Centre (2005–Present), where he also leads as the Physics On-Call Lead (2010–Present). His research contributions are further reflected in his role as a Clinician Investigator at the Princess Margaret Cancer Research Institute (2023–Present) and his affiliation with the Acceleration Consortium at the University of Toronto (2024–Present).

Previously, Dr. Chow held multiple key positions, including Assistant Professor in Radiation Oncology at the University of Toronto (2006–2019) and Medical Physics Site Lead for Skin Cancer at Princess Margaret Cancer Centre (2010–2015). Before joining Princess Margaret, he worked as a Medical Physicist and Deputy Radiation Safety Officer at Grand River Regional Cancer Centre (2002–2005). He has also contributed to academia as an Adjunct Professor at Ryerson University and the University of Waterloo (2005–2010). His career reflects a deep commitment to advancing medical physics, cancer treatment, and interdisciplinary research in materials science and engineering.

Research Interests📚

Dr. Chow’s research focuses on:

Radiation Oncology & Medical Physics: Treatment optimization using Monte Carlo simulations

Artificial Intelligence in Healthcare: AI-driven diagnostic tools and chatbot applications in oncology

Nanotechnology in Radiation Therapy: Gold nanoparticle-enhanced radiotherapy

Clinical Data Analysis: Predictive modeling for cancer treatment outcomes

Awards & Recognitions🏆

2024 Outstanding Reviewer, Nuclear Engineering and Technology Journal

2024 Most-Viewed Article, JMIR Cancer

2024 Outstanding Author of the Year, AIMS Biophysics Journal

2019 Top Peer Reviewer, Web of Science Group

2012 Outstanding Reviewer, Medical Physics Journal

2010 SciNet Local Resource Allocation Award (1 million supercomputing hours for Monte Carlo simulations)

Selected Publications📖

Gold nanoparticles for drug delivery and cancer therapy
S Siddique, JCL Chow
Applied Sciences 10(11), 3824 (2020) – Cited: 382

Chatbot for health care and oncology applications using artificial intelligence and machine learning: Systematic review
L Xu, L Sanders, K Li, JCL Chow
JMIR Cancer 7(4), e27850 (2021) – Cited: 375

Application of nanomaterials in biomedical imaging and cancer therapy
S Siddique, JCL Chow
Nanomaterials 10(9), 1700 (2020) – Cited: 325

Irradiation of gold nanoparticles by X‐rays: Monte Carlo simulation of dose enhancements and the spatial properties of secondary electron production
MKK Leung, JCL Chow, BD Chithrani, MJG Lee, B Oms, DA Jaffray
Medical Physics 38(2), 624-631 (2011) – Cited: 311

Machine learning in healthcare communication
S Siddique, JCL Chow
Encyclopedia 1(1), 220-239 (2021) – Cited: 142

 

 

Dr. Jad El Masri | Medical Research | Young Scientist Award

Dr. Jad El Masri | Medical Research | Young Scientist Award

American University of Beirut, Lebanon.

Dr. Jad El Masri is a postdoctoral research fellow at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard. With a strong background in clinical research, pathology, and neuroscience, he has contributed significantly to oncology, epidemiology, and neurosurgery. Holding an MD and multiple master’s degrees, he is set to complete his PhD in Clinical Research and Pathology in 2025. With over 45 completed research projects and 43 publications, Dr. El Masri has been recognized for his work in cancer biomarkers, epidemiological risk factors, and computational biology.

Profile

Google Scholar

🎓 Education

Dr. Jad El Masri has a diverse academic background spanning clinical research, pathology, neuroscience, and medical sciences. He is currently completing his PhD in Clinical Research & Pathology at Université Paris-Est (2022–2025) while holding multiple master’s degrees in Human Morphology, Clinical Investigation, and Neuroscience from leading institutions, including the American University of Beirut and Lebanese University. In addition, he earned his Medical Degree (MD) from Lebanese University (2018–2024) and holds a Biochemistry License Degree (2017–2020). His academic journey began with a French Baccalaureate in Science from Rawdat Fayhaa Secondary School (2001–2016).

💼 Experience

Dr. Jad El Masri is currently a Postdoctoral Research Fellow at the Broad Institute of MIT & Harvard (2025–Present) and Dana-Farber Cancer Institute (2024–Present), where he focuses on oncology and computational biology. His clinical experience includes multiple internships across hospitals in Lebanon and Germany (2022–2024), gaining hands-on expertise in various medical disciplines. Additionally, he completed elective neurosurgery rotations at the American University of Beirut Medical Center (AUBMC) and Medizinische Hochschule Hannover, further strengthening his specialization in neurosurgery and brain cancer research.

🔬 Research Interests

Oncology – Brain cancer, genetic biomarkers, metastasis

Epidemiology – Risk factors, diet effects, environmental exposure

Neurosurgery – Computational biology, single-cell DNA sequencing

🏆 Awards & Recognitions

Young Scientist Award – Recognized for contributions to neuroscience research

Editorial Board Member – Journal of Public Health Research

Professional Memberships – European Stroke Organization, Congress of Neurological Surgeons

📚 Selected Publications

1️⃣ Social media medical misinformation: Impact on mental health and vaccination decision among university students
📖 Irish Journal of Medical Science (1971-), 192(1), 291-301 (2023)
📄 DOI | Cited by: 34

2️⃣ Menstrual abnormalities post-COVID vaccination: A cross-sectional study on adult Lebanese women
📖 Irish Journal of Medical Science (1971-), 192(3), 1163-1170 (2023)
📄 DOI | Cited by: 27

3️⃣ Contribution of Arab world in transplant research: A PubMed-based bibliometric analysis
📖 Transplant Immunology, 101432 (2021)
📄 DOI | Cited by: 23

4️⃣ Cancer research activity in the Arab world: A 15-year bibliometric analysis
📖 Journal of the Egyptian Public Health Association, 97(1), 26 (2022)
📄 DOI | Cited by: 22

5️⃣ Contribution of Arab countries to familial Mediterranean fever research: A PubMed-based bibliometric analysis
📖 Rheumatology International, 42(1), 95-100 (2022)
📄 DOI | Cited by: 22